Cargando…
Prescription opioid use in multiple sclerosis
Autores principales: | Marrie, Ruth Ann, Fisk, John D, Walld, Randy, Bolton, James M, Sareen, Jitender, Patten, Scott B, Singer, Alexander, Lix, Lisa M, Hitchon, Carol A, El-Gabalawy, Renée, Katz, Alan, Marriott, James J, Bernstein, Charles N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872229/ https://www.ncbi.nlm.nih.gov/pubmed/36028309 http://dx.doi.org/10.1136/jnnp-2022-329508 |
Ejemplares similares
-
Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study
por: Williams, Thomas, et al.
Publicado: (2022) -
Authors’ response: A systematic review of the association between pleural plaques and changes in lung function
por: Kopylev, Leonid, et al.
Publicado: (2015) -
Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus
por: Moyes, Lisa H, et al.
Publicado: (2016) -
Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2023) -
Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme
por: Meyer, Thomas, et al.
Publicado: (2020)